Zillow Group to Announce Third Quarter 2017 Results on November 7
Oct 24, 2017 20:05 pm UTC| Business
SEATTLE, Oct. 24, 2017 -- Zillow Group, Inc. (NASDAQ:Z) and (NASDAQ:ZG), which houses a portfolio of the largest and most vibrant real estate and home-related brands on mobile and web, today announced that it will...
Oct 24, 2017 20:04 pm UTC| Business
NEW YORK, Oct. 24, 2017 -- Solar Senior Capital Ltd. (NASDAQ:SUNS) ("Solar Senior" or the "Company") announces that it acquired 100% of the equity interests of North Mill Capital LLC ("North Mill" or “NMC”). North Mill...
Relievant Medsystems Announces First Patient Enrollment in the INTRACEPT Clinical Study
Oct 24, 2017 20:03 pm UTC| Business
SUNNYVALE, Calif., Oct. 24, 2017 -- Relievant Medsystems, a privately held medical device company that has developed the Intracept® Procedure, a minimally invasive and clinically proven approach for the treatment of...
Northeast Bancorp Reports First Quarter Results and Declares Dividend
Oct 24, 2017 20:02 pm UTC| Business
LEWISTON,Maine, Oct. 24, 2017 -- Northeast Bancorp (“Northeast” or the “Company”) (NASDAQ:NBN), a Maine-based full-service financial services company and parent of Northeast Bank (the “Bank”), today reported net income...
Mercury Systems Reports First Quarter Results
Oct 24, 2017 20:01 pm UTC| Business
First Quarter Highlights Include:Revenue up 21% over prior yearBacklog sets new recordRevenue, EPS, adjusted EPS and adjusted EBITDA exceed consensus estimates ANDOVER, Mass., Oct. 24, 2017 -- Mercury Systems, Inc....
Oct 24, 2017 20:01 pm UTC| Business
MIDLAND, Texas, Oct. 24, 2017 -- Viper Energy Partners LP (NASDAQ:VNOM) ("Viper" or the “Company”), a subsidiary of Diamondback Energy, Inc. (NASDAQ:FANG) ("Diamondback"), today announced financial and operating results...
Idera Pharmaceuticals Provides Corporate Governance Update
Oct 24, 2017 20:01 pm UTC| Business
CAMBRIDGE, Mass. and EXTON, Pa., Oct. 24, 2017 -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with cancer and...